[PLX] YoY Quarter Result on 31-Mar-2018 [#Q1]

Stock
[PLX] Protalix BioTherapeutics, Inc.
Announcement Date
09-May-2018
Financial Year
2018
Quarter
31-Mar-2018 [#Q1]
Profit Trend
QoQ- 37.92%
YoY- 84.11%
Quarter Report
PLX's Result
PLX's Financial Summary
View:
Show?
Quarter Result
31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 CAGR
Revenue 11,320 21,646 10,439 4,553 2,889 679 5,097 14.20%
PBT -5,475 1,667 -7,264 -9,400 -59,148 -8,526 -5,972 -1.43%
Tax 2,207 203 190 132 2,087 314 28 106.92%
NP -5,475 1,667 -7,264 -9,400 -59,148 -8,598 -5,972 -1.43%
Tax Rate - -12.18% - - - - - -
Total Cost 16,795 19,979 17,703 13,953 62,037 9,277 11,069 7.18%
Ratio Analysis
31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 CAGR
NP Margin -48.37 7.70 -69.59 -206.46 -2,047.35 -1,266.27 -117.17 -13.69%
Per Share
31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 CAGR
EPS -0.14 0.10 -0.49 -0.65 -4.75 -0.09 -0.06 15.15%
EPS Diluted -0.14 0.10 -0.49 -0.65 -4.75 -0.09 -0.06 15.15%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.